Ugne Balaseviciute

4PUBLICATIONS
51CO-AUTHORS
Haematological tumoursMolecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Dec 08, 2025
Effective therapeutic targeting of CTNNB1-mutant hepatoblastoma with WNTinib.

Ugne Balaseviciute, Júlia Huguet-Pradell, Jordi Abril-Fornaguera

|Sep 23, 2025
E7386 Enhances Lenvatinib's Antitumor Activity in Preclinical Models and Human Hepatocellular Carcinoma.

Agavni Mesropian, Albert Gris-Oliver, Ugne Balaseviciute

|Feb 13, 2023
Identification of IGF2 as Genomic Driver and Actionable Therapeutic Target in Hepatoblastoma.

Jordi Abril-Fornaguera, Laura Torrens, Carmen Andreu-Oller

|Jun 22, 2021
Immunomodulatory Effects of Lenvatinib Plus Anti-Programmed Cell Death Protein 1 in Mice and Rationale for Patient Enrichment in Hepatocellular Carcinoma.

Laura Torrens, Carla Montironi, Marc Puigvehí

Pageof 1

Frequent Collaborators

4 joint publications

Josep M Llovet

4 joint publications

Jordi Abril-Fornaguera

3 joint publications

Carla Montironi

3 joint publications

Ernesto Guccione